AN ACT relating to reproductive health services.
HB 550 is a broad reproductive health services bill that would create and expand statutory protections and insurance coverage for contraception in Kentucky. It establishes a statutory right for individuals to obtain and use contraceptives and for health care providers to furnish contraception-related services and information, while also limiting state and local government actions that would restrict access. The bill authorizes the Attorney General and private parties to sue over violations, allows injunctive relief and attorney fees, and bars enforcement of conflicting state or local provisions.
The bill also requires most health benefit plans to cover FDA-approved contraceptives, sterilization procedures, counseling, follow-up care, and certain long-acting reversible contraception, generally without deductibles, copays, or other cost-sharing. It includes rules for over-the-counter products, extended 12-month supplies, therapeutic equivalents, and coverage when a provider deems a method medically inadvisable. Religious employers may opt out of contraceptive coverage, but must provide notice to enrollees. Separate provisions require Medicaid, KCHIP, state employee plans, and postsecondary institution plans to comply with the contraception coverage mandate, with some exceptions and delayed effective dates.
Beyond insurance coverage, the bill directs the Cabinet for Health and Family Services to seek federal approval for a Medicaid family planning program for low-income individuals and authorizes pharmacists to provide hormonal contraceptives under collaborative care agreements and standardized procedures. It also contains conforming changes to Kentucky insurance and public employee health plan statutes, plus provisions intended to align the bill with federal essential health benefits and cost-defrayal rules. Most major provisions are set to take effect on January 1, 2027.
The overall sentiment in the available record appears neutral to supportive in concept, but the absence of committee transcripts or recorded votes means there is no direct evidence of debate or organized opposition in the provided materials. The bill’s structure suggests a strong policy push to expand access to contraception and reduce barriers in insurance coverage and pharmacy access. At the same time, its inclusion of a religious-employer exemption and multiple federal-compliance provisions indicates an effort to address anticipated legal and constitutional concerns.
Notable points of contention likely center on the scope of the new statutory right, the requirement that plans cover contraception without cost-sharing, the bill’s limits on state and local restrictions, and the interaction with religious liberty and insurance mandates. The bill expressly states that its provisions should not be construed to violate Kentucky’s Religious Freedom Restoration Act, but it also overrides conflicting laws and authorizes litigation against governments or persons enforcing restrictions. Questions may also arise over whether the mandated benefits create additional essential health benefits, whether federal waivers or state plan amendments are needed, and how the new requirements affect insurers, public employers, Medicaid, KCHIP, and higher education health plans.
HB 550 would add new sections to Kentucky law creating enforceable rights to contraception access and requiring broad contraceptive coverage in health benefit plans, Medicaid-related programs, KCHIP, state employee plans, and certain postsecondary institution plans. It would amend multiple statutes in KRS Chapters 205, 304, 315, 446, and 164, and would also authorize pharmacist provision of hormonal contraceptives under state-regulated protocols. The bill would significantly affect insurers, public benefit programs, employers with religious objections, health care providers, pharmacists, and state agencies responsible for insurance and Medicaid administration.
No committee testimony or vote history was provided, so the record does not show direct floor or committee sentiment. Based on the bill text, the measure is framed as an access-expanding reproductive health policy with detailed implementation rules, suggesting a generally pro-contraception policy posture. The inclusion of religious exemptions and federal-waiver language indicates the sponsors anticipated legal sensitivity and sought to make the bill more defensible and administratively workable.
The main areas of likely contention are religious liberty, insurance mandates, and state-federal preemption issues. Religious employers are allowed to opt out, but the bill still requires notice and otherwise imposes broad coverage obligations, which could draw objections from faith-based organizations and opponents of contraceptive mandates. Insurers and public employers may also object to the cost and administrative burden of no-cost coverage, extended supplies, and reimbursement requirements. Finally, the bill’s attempt to override conflicting laws and its reliance on federal essential health benefits and waiver procedures could prompt disputes over legality, implementation timing, and whether the state must make cost-defrayal payments.